Cargando…
Mast Cell Stabilizers in the Treatment of Rosacea: A Review of Existing and Emerging Therapies
Rosacea is a chronic inflammatory skin disease characterized by centrofacial erythema, papules, pustules, and telangiectasias. The onset of rosacea typically occurs after 30 years of age. It is estimated that approximately 2–5% of adults worldwide are affected. While the exact etiology of rosacea re...
Autores principales: | Marchitto, Mark C., Chien, Anna L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484408/ https://www.ncbi.nlm.nih.gov/pubmed/34476755 http://dx.doi.org/10.1007/s13555-021-00597-7 |
Ejemplares similares
-
The Theranostics Role of Mast Cells in the Pathophysiology of Rosacea
por: Wang, Lian, et al.
Publicado: (2020) -
Rosacea: Epidemiology, pathogenesis, and treatment
por: Rainer, Barbara M., et al.
Publicado: (2017) -
Emerging Medical Therapies in Rosacea: A Narrative Review
por: Choe, James, et al.
Publicado: (2023) -
Mast cells are key mediators of cathelicidin initiated skin inflammation in rosacea
por: Muto, Yumiko, et al.
Publicado: (2014) -
Rosacea Treatment: Review and Update
por: Zhang, Hanlin, et al.
Publicado: (2020)